文献速递药物不良反应与药物警戒特殊人群用药

哺乳期用药:里昂药物警戒中心五年真实世界咨询经验

Medication Use During Breastfeeding-An Understudied Population: A Five-Year Experience in the Pharmacovigilance Center of Lyon.
PubMed 文献 · Clin Pharmacol Ther · 2026-10-06

87%的咨询建议支持哺乳(无条件或附条件),仅13%给出不支持建议;联合用药占35%且与更严格的建议相关。

要点

  • 87%的咨询建议支持继续哺乳,可无条件或附条件(临床监测、调整治疗、调整给药时间)。
  • 联合用药占35%,与更严格的哺乳建议相关。
  • 婴儿报告的不良反应罕见且非严重。

核心结论

  • 多数情况下可给出支持哺乳的建议,但复杂或资料匮乏情形仍存在不确定性。
  • 需可靠可及的信息、将哺乳期女性纳入临床研究并加强监管与上市后评价。

主要发现

  • 咨询来源:患者44%、相关卫生专业人员29%、专科医生25%,三分之二发生在产后。
  • 87%的建议支持哺乳,可无条件或附条件(临床监测、治疗调整、时间安排策略)。
  • 13%为不支持建议,原因包括正式禁忌、治疗获益不足或安全性数据有限。
  • 联合用药占35%,且与更严格的建议相关。
  • 慢性病用药占36%(如抗高血压药、抗癫痫药、精神药物);急性病治疗包括抗感染药、镇痛药、造影剂或麻醉药;婴儿报告的不良反应罕见且非严重。

临床怎么用

  • 哺乳期用药咨询多数可支持继续哺乳,但需结合联合用药与资料充分性评估是否附加监测或时序调整条件。

局限性

  • 为单中心描述性观察研究,基于咨询请求记录,未提供药物暴露与婴儿结局的因果验证数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Medication use during breastfeeding is common, yet data on drug transfer into breast milk and infant exposure remain limited. This study describes real-world requests concerning medication compatibility with breastfeeding managed by the Lyon pharmacovigilance center over five years. We conducted a descriptive observational study including all requests recorded between January 2019 and December 2023. Characteristics of infants, medications involved, and recommendations provided were analyzed. A total of 2,473 requests were included, corresponding to approximately 500 per year. Most requests originated from patients (44%), allied health professionals (29%), or specialists (25%), with two thirds occurring postpartum. Overall, our recommendations supported breastfeeding in 87% of cases, either unconditionally or under specific conditions, such as clinical monitoring, therapeutic adjustments, or timing strategies. Only 13% of cases resulted in an unfavorable recommendation, for either treatment or breastfeeding discontinuation, due to formal contraindications, insufficient therapeutic benefit, or limited safety data. Polytherapy was observed in 35% of cases and was associated with more restrictive recommendations. Medications used for chronic conditions accounted for 36% of cases such as antihypertensives, antiepileptics, or psychotropic agents. Treatments for acute conditions included anti-infectives, analgesics, contrast agents, or anesthetics. Reported adverse effects in infants were rare and non-serious. In most cases, a recommendation supporting breastfeeding during maternal treatment, with or without conditions, was provided. However, uncertainty persists, particularly in complex or poorly documented situations. This work highlights the need for reliable, accessible information, inclusion of breastfeeding women in clinical research, and strengthened regulatory and postmarketing evaluation strategies to ensure infant safety health.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Bertin B, Gouraud A, Facile A, et al. Medication Use During Breastfeeding-An Understudied Population: A Five-Year Experience in the Pharmacovigilance Center of Lyon. Clin Pharmacol Ther. 2026. PMID: 42836278. doi:10.1002/cpt.70518

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。